Bank of America’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.9M | Sell |
|
|||||
|
2025
Q2 | $78.7M | Buy |
|
|||||
|
2025
Q1 | $62.3M | Buy |
|
|||||
|
2024
Q4 | $17.3M | Sell |
|
|||||
|
2024
Q3 | $65.4M | Sell |
|
|||||
|
2024
Q2 | $71.7M | Buy |
|
|||||
|
2024
Q1 | $14.8M | Buy |
|
|||||
|
2023
Q4 | $14M | Buy |
|
|||||
|
2023
Q3 | $2.59M | Buy |
|
|||||
|
2023
Q2 | $2.09M | Sell |
|
|||||
|
2023
Q1 | $2.01M | Buy |
|
|||||
|
2022
Q4 | $2.41M | Sell |
|
|||||
|
2022
Q3 | $1.71M | Sell |
|
|||||
|
2022
Q2 | $2.09M | Buy |
|
|||||
|
2022
Q1 | $1.88M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Sell |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|
|||||
|
2021
Q2 | $1.96M | Sell |
|
|||||
|
2021
Q1 | $1.71M | Buy |
|
|||||
|
2020
Q4 | $2.04M | Buy |
|
|||||
|
2020
Q3 | $781K | Sell |
|
|||||
|
2020
Q2 | $1.43M | Sell |
|
|||||
|
2020
Q1 | $1.12M | Sell |
|
|||||
|
2019
Q4 | $2.42M | Buy |
|
|||||
|
2019
Q3 | $463K | Sell |
|
|||||
|
2019
Q2 | $737K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $7K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $24K | Buy |
|
|||||
|
2017
Q1 | $13K | Buy |
|
|||||
|
2016
Q4 | $10K | Buy |
|
|||||
|
2016
Q3 | $4K | Sell |
|
|||||
|
2016
Q2 | $10K | Buy |
|